Drugs / protein vaccination
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00106158 | Jun 2004 → Dec 2006 | neoplasm | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | protein vaccination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00106158 ↗ |
| Known as | NY-ESO-1 protein | “NY-ESO-1 protein (CHP-NY-ESO-1)” NCT00106158 ↗ |
| Modality | Vaccine | “NY-ESO-1 Protein Vaccine” NCT00106158 ↗ |